POLYMEDIX, INC
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY11 | FY10 | FY09 | |
|---|---|---|---|
| Revenue | $9.2M | $2.1M | $1.0M |
| Operating income | — | — | — |
| Net income | −$84.1M | −$15.5M | −$11.8M |
| Total assets | $22.7M | $22.4M | — |
| Total liabilities | $17.3M | $13.2M | — |
| Equity | $5.4M | $9.2M | $22.3M |
| EPS (diluted) | $-0.20 | $-0.19 | $-0.19 |
| Shares out. | 106,000 | 81,000 | 62.4M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2011- Operating margin
- —
- Net margin
- −918.3%
- Return on equity
- −1562.7%
- Return on assets
- −371.4%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 76.2%
- Debt / equity
- 3.21×
- Book value / share
- $50.79
- Revenue growth (YoY)
- 327.3%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2011- Accruals / assets
- −81.3%clean
- Piotroski F-Score
- 2/8weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 warning● 2 good- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Bankruptcy or receivership · Debt acceleration / triggering event · Director / officer changeApr 1, 2013
- Other material eventMar 21, 2013
- Modified shareholder rights · Shareholder voteMar 15, 2013
- Director / officer changeMar 7, 2013
- Entered a material agreement · Results of operationsMar 6, 2013
- Director / officer changeJan 30, 2013
- Entered a material agreement · Regulation FD disclosureJan 23, 2013
- Results of operationsNov 9, 2012
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- REVOKEDSep 10, 2015
- 8-KFORM 8-KApr 1, 2013
- 8-KFORM 8-KMar 21, 2013
- 424B5Mar 18, 2013
- 8-KFORM 8-KMar 15, 2013
- 8-KFORM 8-KMar 7, 2013
- FWPMar 7, 2013
- 424B5PROSPECTUSMar 7, 2013
- DEFA14ADEFINITIVE ADDITIONAL MATERIALSMar 7, 2013
- 8-KFORM 8-KMar 6, 2013
- DEFA14AADDITIONAL SOLICITATION MATERIALSMar 6, 2013
- DEF 14ADEFINITIVE PROXYFeb 22, 2013
- UPLOADFeb 21, 2013
- CORRESPFeb 21, 2013
- UPLOADFeb 21, 2013